Skip to Main content Skip to Navigation
Conference papers

O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide

Js Guillamo 1 G Levallet 1 A Dugué 1 A Vital 1 Md Diebold 1 P Menei 1 P Colin 1 P Peruzzy 1 E Emery 1 M Bernaudin 2 F Chapon 1 E Lechapt-Zalcman 2
2 CERVOxy - Hypoxie, physiopathologies cérébrovasculaire et tumorale
ISTCT - Imagerie et Stratégies Thérapeutiques des pathologies Cérébrales et Tumorales
Document type :
Conference papers
Complete list of metadatas

https://hal-normandie-univ.archives-ouvertes.fr/hal-02265457
Contributor : Carole Brunaud <>
Submitted on : Friday, August 9, 2019 - 5:04:13 PM
Last modification on : Tuesday, September 8, 2020 - 10:20:04 AM

Identifiers

  • HAL Id : hal-02265457, version 1

Citation

Js Guillamo, G Levallet, A Dugué, A Vital, Md Diebold, et al.. O6-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated with Biodegradable Carmustine Wafer Implants after Initial Surgery Followed by Radiotherapy with Concomitant and Adjuvant Temozolomide. 64th Annual Meeting of the American-Academy-of-Neurology (AAN), Apr 2012, New Orleans, United States. pp.P06.004. ⟨hal-02265457⟩

Share

Metrics

Record views

36